Panacea Life Sciences Holdings, Inc. (PLSH) stock
PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Panacea Life Sciences cash
Cash and short-term investments held at the end of each period.
Panacea Life Sciences's cash was $117.15K at Mar 31, 2024. For fiscal 2023 it was $115.86K, down 89.6% from the year before. Over ten years it grew 12.6% a year on average. The highest annual figure on record is $3.81M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $115.86K | -89.6% |
| FY2022 | Dec 31, 2022 | $1.11M | -70.8% |
| FY2021 | Dec 31, 2021 | $3.81M | +29.7% |
| FY2020 | Dec 31, 2020 | $2.94M | +15862.1% |
| FY2019 | Dec 31, 2019 | $18.41K | +839.0% |
| FY2018 | Dec 31, 2018 | $1.96K | -98.8% |
| FY2017 | Dec 31, 2017 | $161.22K | -84.7% |
| FY2016 | Dec 31, 2016 | $1.06M | – |
| FY2015 | Dec 31, 2015 | $0 | -100.0% |
| FY2014 | Dec 31, 2014 | $42.50K | +19.7% |
| FY2013 | Dec 31, 2013 | $35.50K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2024 | Mar 31, 2024 | $117.15K | -88.3% |
| Q4 FY2023 | Dec 31, 2023 | $115.86K | -89.6% |
| Q3 FY2023 | Sep 30, 2023 | $79.92K | -93.1% |
| Q2 FY2023 | Jun 30, 2023 | $468.58K | -82.0% |
| Q1 FY2023 | Mar 31, 2023 | $998.34K | -65.6% |
| Q4 FY2022 | Dec 31, 2022 | $1.11M | -70.8% |
| Q3 FY2022 | Sep 30, 2022 | $1.15M | -68.4% |
| Q2 FY2022 | Jun 30, 2022 | $2.60M | -57.6% |
| Q1 FY2022 | Mar 31, 2022 | $2.90M | +14618.7% |
| Q4 FY2021 | Dec 31, 2021 | $3.81M | +29.7% |
| Q3 FY2021 | Sep 30, 2021 | $3.65M | +6074.9% |
| Q2 FY2021 | Jun 30, 2021 | $6.14M | +1953.8% |
| Q1 FY2021 | Mar 31, 2021 | $19.72K | +106.7% |
| Q4 FY2020 | Dec 31, 2020 | $2.94M | +15862.1% |
| Q3 FY2020 | Sep 30, 2020 | $59.05K | +938.6% |
| Q2 FY2020 | Jun 30, 2020 | $298.75K | -55.1% |
| Q1 FY2020 | Mar 31, 2020 | $9.54K | -99.2% |
| Q4 FY2019 | Dec 31, 2019 | $18.41K | +839.0% |
| Q3 FY2019 | Sep 30, 2019 | $5.69K | +340.4% |
| Q2 FY2019 | Jun 30, 2019 | $664.65K | +1130.6% |
| Q1 FY2019 | Mar 31, 2019 | $1.17M | +2912.5% |
| Q4 FY2018 | Dec 31, 2018 | $1.96K | -98.8% |
| Q3 FY2018 | Sep 30, 2018 | $1.29K | -96.1% |
| Q2 FY2018 | Jun 30, 2018 | $54.01K | +198.3% |
| Q1 FY2018 | Mar 31, 2018 | $38.94K | -86.9% |
| Q4 FY2017 | Dec 31, 2017 | $161.22K | -84.7% |
| Q3 FY2017 | Sep 30, 2017 | $32.97K | -4.4% |
| Q2 FY2017 | Jun 30, 2017 | $18.10K | -53.3% |
| Q1 FY2017 | Mar 31, 2017 | $296.91K | +30.7% |
| Q4 FY2016 | Dec 31, 2016 | $1.06M | – |
| Q3 FY2016 | Sep 30, 2016 | $34.49K | +194.2% |
| Q2 FY2016 | Jun 30, 2016 | $38.78K | +2.3% |
| Q1 FY2016 | Mar 31, 2016 | $227.09K | +434.4% |
| Q4 FY2015 | Dec 31, 2015 | $0 | -100.0% |
| Q3 FY2015 | Sep 30, 2015 | $11.73K | -88.4% |
| Q1 FY2015 | Mar 31, 2015 | $37.92K | +6.8% |
| Q4 FY2014 | Dec 31, 2014 | $42.50K | – |
| Q3 FY2014 | Sep 30, 2014 | $86.19K | – |
| Q2 FY2014 | Jun 30, 2014 | $101.33K | – |
| Q4 FY2013 | Dec 31, 2013 | $35.50K | – |
See a number that looks wrong?